Eli Lilly and Company (NYSE: LLY) has agreed to acquire AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing treatments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions